Targeting glioma stem cells enhances anti-tumor effect of boron neutron capture therapy

The uptake of ((10))boron by tumor cells plays an important role for cell damage in boron neutron capture therapy (BNCT). CD133 is frequently expressed in the membrane of glioma stem cells (GSCs), resistant to radiotherapy and chemotherapy, and represents a potential therapeutic target. To increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Ting, Li, Yanyan, Huang, Yulun, Zhang, Zizhu, Yang, Weilian, Du, Ziwei, Zhou, Youxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190011/
https://www.ncbi.nlm.nih.gov/pubmed/27191269
http://dx.doi.org/10.18632/oncotarget.9355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190011/
https://www.ncbi.nlm.nih.gov/pubmed/27191269
http://dx.doi.org/10.18632/oncotarget.9355

Ejemplares similares